Intensive Symptom Surveillance Guided by Machine Learning-Directed Risk Stratification in Patients With Non-Metastatic Head and Neck Cancer, The INSIGHT Trial

NAActive, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 11, 2022

Primary Completion Date

December 17, 2025

Study Completion Date

August 25, 2026

Conditions

Head and Neck Squamous Cell Carcinoma

Interventions

OTHER

Palliative Therapy

Receive standard symptom management

OTHER

Quality-of-Life Assessment

Complete quality of life questionnaire

OTHER

Questionnaire Administration

Complete quality of life questionnaire

Trial Locations (1)

Roswell Park Cancer Institute, Buffalo

All Listed Sponsors

lead

Roswell Park Cancer Institute

OTHER